AGIO DCF Valuation - Agios Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 34.19 USD 1.06% Market Closed

Market Cap: $2B

	Agios Pharmaceuticals Inc NASDAQ:AGIO	US
	Hut 8 Mining Corp TSX:HUT	CA
	Pfizer Inc NYSE:PFE	US
	Adherium Ltd ASX:ADR	NZ
S	SM Bexel Co Ltd KRX:010580	KR
	Investigator Resources Ltd ASX:IVR	AU
	CVS Group PLC LSE:CVSG	UK
I	IBI Investment House Ltd TASE:IBI	IL
	Thomas Cook (India) Ltd NSE:THOMASCOOK	IN
	SVG Tech Group Co Ltd SZSE:300331	CN
V	Vector Inc TSE:2656	JP
	Vesync Co Ltd HKEX:2148	US
R	Revenga Ingenieros SA MAD:RSS	ES
M	McDonald's Corp SGO:MCD	US
O	Opus Global Nyrt BET:OPUS	HU
E	Exsitec Holding AB STO:EXS	SE
S	S&T Holdings Ltd HKEX:3928	SG
	Cordoba Minerals Corp XTSX:CDB	CA
	Reliance Industries Ltd NSE:RELIANCE	IN
L	Llorente & Cuenca SA MAD:LLYC	ES
X	Xinhu Zhongbao Co Ltd SSE:600208	CN
	Astra Industrial Group Company SJSC SAU:1212	SA
B	Budweiser Brewing Company APAC Ltd OTC:BDWBF	HK

AGIO's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.